Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Reliance Industries to launch Rs 12,000 DNA testing kit

2 Mar 2023 , 10:50 AM

Reliance Industries is entering the field of genetic mapping in an effort to spread and lower the cost of a health care trend being driven by innovative American businesses like 23andMe, in India’s expanding consumer market.

According to Ramesh Hariharan, CEO of Strand Life Sciences Pvt. who talked to ET – which created the product – the energy-to-ecommerce giant would launch a thorough Rs 12,000 ($145) genome sequencing test in the coming weeks. The Bengaluru-based company was purchased by Reliance Industries Ltd. in 2021, which now owns around 80% of it.

The genome test can disclose a person’s propensity for malignancies, cardiac and neuro-degenerative diseases, as well as identify inherited genetic problems, he said. It is also around 86% less expensive than other options accessible locally.

The initiative to make personal gene-mapping accessible to India’s 1.4 billion citizens, who are on track to become the world’s most populated country, may produce a wealth of biological information that may help with the region’s medication development and illness prevention. 

It also fits in with Mukesh Ambani’s plans to expand his data-related endeavors, which he has frequently referred to as the ‘new oil,’ as he transitions his $192 billion business from the refining industry to consumer and digital services.

Pricing disruption is natural to Ambani, who used a similar aggressive tactic when it entered the retail industry in 2006 and the telecommunications industry in 2016, crushing rivals until Reliance became the market leader in both industries.

According to a survey from Allied Market Research, the global market for genetic testing was estimated to be worth $12.7 billion in 2019 and is projected to reach $21.3 billion by 2027.

Nevertheless, in a market like India where understanding of such services and their advantages is still largely unproven, cheap pricing alone might not be sufficient to entice customers. Reliance’s $145 price tag, while less expensive than its international competitors, is nevertheless high for the average Indian consumer.

For feedback and suggestions, write to us at


Related Tags

  • Ambani
  • Genome Testing
  • India
  • reliance
sidebar mobile


Read More

Most Read News

Sensex and Nifty close in Red
24 Jul 2024|04:29 PM
Over 23 Lakh New Enrollments for ESIC in May
24 Jul 2024|01:34 PM
Read More
Knowledge Centerplus

Logo IIFL Customer Care Number
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

Knowledge Centerplus

Follow us on


2024, IIFL Securities Ltd. All Rights Reserved

  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.